Aids 2026 [upd] Info

As we move through 2026, the global health community has hit a strange inflection point. We are no longer talking about "dying from AIDS" in the same way we talked about it ten years ago. We are talking about a new, quieter crisis: The Last Mile Problem.

The problem isn't dying of AIDS in 2026. It's living with HIV and facing a frail body at 60. Geriatric HIV care is the specialty no one trained for, and we are scrambling to catch up. aids 2026

You have heard the rumors about the CRISPR cure. In 2026, we are still waiting for the "London Patient" miracle to become a pharmacy product. Gene editing is expensive ($2 million per patient). It works. But it isn't scalable. As we move through 2026, the global health

We are not at the end of AIDS. But we are finally, painfully, at the beginning of the end. The problem isn't dying of AIDS in 2026

In 2026, the largest cohort of people living with HIV in North America and Western Europe are over 55 years old.

Here is the state of play.